Order Article Reprints

Eibensteiner F, Mosor E, Tihanyi D, Anders S, Kornfehl A, Neymayer M, Oppenauer J, Veigl C, Al Jalali V, Domanovits H, et al. The Impact of Chronic Oral Beta-Blocker Intake on Intravenous Bolus Landiolol Response in Hospitalized Intensive Care Patients with Sudden-Onset Supraventricular Tachycardia—A Post Hoc Analysis of a Cross-Sectional Trial. Pharmaceutics. 2024; 16(6):839. https://doi.org/10.3390/pharmaceutics16060839

Eibensteiner, Felix, Emmilie Mosor, Daniel Tihanyi, Sonja Anders, Andrea Kornfehl, Marco Neymayer, Julia Oppenauer, Christoph Veigl, Valentin Al Jalali, Hans Domanovits, and et al. 2024. "The Impact of Chronic Oral Beta-Blocker Intake on Intravenous Bolus Landiolol Response in Hospitalized Intensive Care Patients with Sudden-Onset Supraventricular Tachycardia—A Post Hoc Analysis of a Cross-Sectional Trial" Pharmaceutics 16, no. 6: 839. https://doi.org/10.3390/pharmaceutics16060839

Eibensteiner, F., Mosor, E., Tihanyi, D., Anders, S., Kornfehl, A., Neymayer, M., Oppenauer, J., Veigl, C., Al Jalali, V., Domanovits, H., Sulzgruber, P., & Schnaubelt, S. (2024). The Impact of Chronic Oral Beta-Blocker Intake on Intravenous Bolus Landiolol Response in Hospitalized Intensive Care Patients with Sudden-Onset Supraventricular Tachycardia—A Post Hoc Analysis of a Cross-Sectional Trial. Pharmaceutics, 16(6), 839. https://doi.org/10.3390/pharmaceutics16060839